Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests for the early detection of multiple cancers.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk

Description

Urteste S.A. is a biotechnology company specializing in the development of non-invasive diagnostic technologies for early cancer detection. The company's core focus is on creating a method to detect multiple types of cancer from a single urine sample. This approach aims to identify malignancies at their earliest stages, potentially improving patient survival rates. The development pipeline includes diagnostic tests for various cancers, with projects such as a prototype for detecting brain tumors and planned clinical trials for a pancreatic cancer test.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 16:00
INFORMACJE DOTYCZĄCE PRZETWARZANIA DANYCH OSOBOWYCH AKCJONARIUSZY I PEŁNOMOCNIK…
Polish 191.5 KB
2025-11-07 16:00
INFORMACJA o ogólnej liczbie akcji w Spółce Urteste S.A.
Polish 118.9 KB
2025-11-07 16:00
FORMULARZ pozwalający na wykonywanie prawa głosu przez pełnomocnika
Polish 284.9 KB
2025-11-07 16:00
Ogłoszenie Zarządu Urteste S.A.
Polish 217.3 KB
2025-11-07 16:00
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 4 grudnia 2025 roku - Con…
Polish 1.5 KB
2025-11-07 10:36
Zawarcie dwóch umów inwestycyjnych dotyczących dokapitalizowania Spółki - Conte…
Polish 2.6 KB
2025-10-31 10:46
Zawarcie umowy z firmą typu CRO - rozpoczęcie wieloośrodkowego badania kliniczn…
Polish 3.2 KB
2025-10-20 17:09
Zawarcie umowy pożyczki - Content (PL)
Polish 1.4 KB
2025-09-29 17:38
Opinia biegłego
Polish 366.5 KB
2025-09-29 17:38
Sprawozdanie z działalności Zarządu za I półrocze 2025
Polish 1.0 MB
2025-09-29 17:38
Sprawozdanie finansowe za I półrocze 2025
Polish 1.2 MB
2025-08-05 16:08
Uzyskanie ochrony patentowej od Urzędu Patentowego Rzeczypospolitej Polskiej na…
Polish 1.2 KB
2025-08-01 15:12
BIO - Przemysław Mencel
Polish 117.1 KB
2025-08-01 15:12
Powołanie Członka Rady Nadzorczej - Content (PL)
Polish 1.2 KB
2025-07-31 20:13
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 446 bytes

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.